We are live on ! Find out more
WFG

Wormser Freres Gestion Portfolio holdings

AUM $177M
1-Year Est. Return 13.84%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+13.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$168M
AUM Growth
+$4.42M
Cap. Flow
+$2.54M
Cap. Flow %
1.51%
Top 10 Hldgs %
55.15%
Holding
49
New
4
Increased
17
Reduced
18
Closed
1

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.54M
2
LLY icon
Eli Lilly
LLY
+$163K
3
UNH icon
UnitedHealth
UNH
+$161K
4
IAU icon
iShares Gold Trust
IAU
+$160K
5
DHR icon
Danaher
DHR
+$160K

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$851K
2
CRM icon
Salesforce
CRM
+$284K
3
ACN icon
Accenture
ACN
+$276K
4
EMR icon
Emerson Electric
EMR
+$250K
5
AMZN icon
Amazon
AMZN
+$145K

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 26.19%
3 Consumer Discretionary 15.88%
4 Communication Services 8.53%
5 Financials 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
1
Amazon
AMZN
$2.66T
$11.2M 6.68%
50,812
-708
-1% -$145K
V icon
2
Visa
V
$686B
$11.1M 6.62%
35,044
-412
-1% -$124K
ACN icon
3
Accenture
ACN
$88.6B
$9.93M 5.9%
28,013
-766
-3% -$276K
CRM icon
4
Salesforce
CRM
$139B
$9.51M 5.65%
28,181
-891
-3% -$284K
EMR icon
5
Emerson Electric
EMR
$76.5B
$9.36M 5.57%
74,810
-2,061
-3% -$250K
SYK icon
6
Stryker
SYK
$122B
$9.29M 5.52%
25,589
+14
+0.1% +$5.19K
PTC icon
7
PTC
PTC
$14.4B
$8.91M 5.3%
48,146
+168
+0.4% +$31.9K
MSFT icon
8
Microsoft
MSFT
$2.95T
$7.86M 4.67%
18,412
+8,322
+82% +$3.54M
TMO icon
9
Thermo Fisher Scientific
TMO
$195B
$7.84M 4.66%
14,953
+222
+2% +$122K
ALC icon
10
Alcon
ALC
$34.2B
$7.68M 4.57%
91,950
-759
-0.8% -$68.4K
ECL icon
11
Ecolab
ECL
$75.6B
$7.46M 4.43%
31,458
+8
+0% +$1.99K
ZTS icon
12
Zoetis
ZTS
$31.6B
$7.42M 4.41%
45,207
+380
+0.8% +$68K
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.24T
$7.13M 4.24%
37,348
-622
-2% -$109K
META icon
14
Meta Platforms (Facebook)
META
$1.63T
$7.13M 4.24%
12,040
-16
-0.1% -$9.39K
EW icon
15
Edwards Lifesciences
EW
$48.9B
$6.89M 4.1%
92,120
-103
-0.1% -$7.21K
AAPL icon
16
Apple
AAPL
$4.81T
$6.81M 4.05%
26,947
-228
-0.8% -$53.7K
ULTA icon
17
Ulta Beauty
ULTA
$21B
$6.31M 3.75%
14,405
-164
-1% -$63.5K
NKE icon
18
Nike
NKE
$63.7B
$5.24M 3.12%
68,841
+288
+0.4% +$22.6K
ALGN icon
19
Align Technology
ALGN
$12.5B
$5.11M 3.04%
24,355
+599
+3% +$134K
ILMN icon
20
Illumina
ILMN
$27.9B
$3.71M 2.21%
27,551
-267
-1% -$38K
APTV icon
21
Aptiv
APTV
$12.1B
$2.8M 1.66%
46,185
-13,895
-23% -$851K
IAU icon
22
iShares Gold Trust
IAU
$63.4B
$2.08M 1.24%
41,403
+3,192
+8% +$160K
DHR icon
23
Danaher
DHR
$127B
$1.21M 0.72%
5,128
+650
+15% +$160K
ISRG icon
24
Intuitive Surgical
ISRG
$125B
$1.13M 0.67%
2,081
+167
+9% +$87K
RACE icon
25
Ferrari
RACE
$65.1B
$1.11M 0.66%
2,597
-113
-4% -$51K

Similar funds

Wormser Freres Gestion's Q4 2024 Portfolio in Review

As of Q4 2024, Wormser Freres Gestion held 49 positions worth $168M, up 2.7% from $164M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Wormser Freres Gestion's Q4 2024 filing shows 4 new, 17 increased, 18 reduced and 1 closed positions. Its largest new stake was KLA: 1,880 shares worth $119K. The largest sale was Aptiv, an estimated $851K.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Wormser Freres Gestion's largest Q4 2024 buy was KLA: 1,880 shares worth $119K.
  • Wormser Freres Gestion added most to Microsoft in Q4 2024, an estimated $3.54M increase.
  • Wormser Freres Gestion's biggest Q4 2024 reduction was Aptiv, cutting an estimated $851K.
  • Wormser Freres Gestion fully exited Johnson & Johnson in Q4 2024, selling an estimated $3.73K.
  • Wormser Freres Gestion's ten largest holdings make up 55% of its $168M portfolio in Q4 2024.
  • Wormser Freres Gestion opened 4 new positions and closed 1 in Q4 2024.
  • Wormser Freres Gestion's portfolio value rose 2.7% quarter-over-quarter to $168M.

Based on Wormser Freres Gestion's 13F filing for Q4 2024, filed 20 Feb 2025.